Evaluation of the effectiveness of a self-help smartphone app for aftercare among patients with depressive symptoms: a randomized controlled trial
Not Applicable
Recruiting
- Conditions
- F32Depressive episode
- Registration Number
- DRKS00022559
- Lead Sponsor
- niversitätsklinikum Hamburg-Eppendorf/Klinik und Poliklinik für Psychiatrie und Psychotherapie/Arbeitsgruppe Klinische Neuropsychologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 149
Inclusion Criteria
at least 18 years old, a psychiatric diagnosis according to ICD-10 (exclusion: dementia), upcoming discharge after inpatient treatment or day-care in a psychiatric hospital (baseline assessment max. 1 week before discharge), informed consent, internet access and smartphone, willingness to participate in two online surveys (approx. 30 minutes each), willingness to take part in the four-week smartphone intervention, willingness to use the smartphone intervention on one's own responsibility, willingness to leave an anonymous e-mail address for the survey, presence of depressive symptoms (measured by PHQ-9), no acute suicidal tendencies (measured by PHQ9, item 9)
Exclusion Criteria
Exclusion: dementia, acute suicidal tendencies
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Rosenberg Self-Esteem Scale (RSE) is used as the primary outcome parameter to measure self-esteem (at T0 and T1 after 4 weeks).
- Secondary Outcome Measures
Name Time Method The Patient Health Questionnaire - 9 Depression Module (PHQ-9) to assess the severity of the depressive symptoms and a Globalitem of the World Health Organization Quality of Life - abbreviated version (WHOQOL-BREF) to measure the quality of life (T0 and T1 after 4 weeks) serve as secondary success parameters. <br>In addition, the Attitude Towards Psychological Online Interventions Questionnaire (APOI), the Patientenfragebogen zur Therapieerwartung und Therapieevaluation (PATHEV), socio-demographic data and therapy experiences are assessed at T0. Possible side effects via the Inventar zur Erfassung negativer Effekte von Psychotherapie (INEP) and patient satisfaction via the Fragebogen zur Messung der Patientenzufriedenheit (ZUF-8) will be assessed at T1 (after 4 weeks).